Jefferies Group LLC Aldeyra Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	BUY	$3.8 - $7.74 $71,820 - $146,286	18,900 Added 117.39%	35,000 $186,000
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $133,000 - $270,900	35,000 New	35,000 $187,000
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $52,325 - $83,237	-16,100 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$3.5 - $9.63 $66,150 - $182,007	-18,900 Reduced 54.0%	16,100 $64,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $56,350 - $155,043	16,100 New	16,100 $64,000
Q2 2019 Aug 14, 2019	SELL	$6.0 - $9.0 $120,000 - $180,000	-20,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $142,800 - $197,000	20,000 New	20,000 $181,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $285M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.